The Motherhood Choices Decision Aid for Women with Rheumatoid Arthritis Increases Knowledge and Reduces Decisional Conflict: A Randomized Controlled Study

Not Applicable

Completed

• Conditions: Rheumatoid Arthritis; Inflammatory and Immune System - Rheumatoid arthritis

• Registration Number: ACTRN12615000523505
• Lead Sponsor: Associate Professor Tanya Meade

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-05-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 130

Inclusion Criteria

Eligible women were those diagnosed with Rheumatoid Arthritis and currently under the care of a rheumatologist.

Exclusion Criteria

Males
Individuals without clinical diagnosis of rheumatoid arthritis
Women not considering motherhood options

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
RA knowledge: measured using Pregnancy in Rheumatoid Arthritis Questionnaire (PiRAQ) which includes questions that correspond to components of the Decision Aid including: <br>general knowledge about RA, the physical and psychosocial effects of RA, effects of RA on fertility and pregnancy, the effects of RA medicines during conception, pregnancy and breastfeeding, postnatal considerations, and parenting with RA. [Baseline and 4 to 12 weeks post intervention (Decision Aid). Follow up timeframe depended on participants' rate of completion (DA use and survey response).];Decisional conflict: measured using the Decisional Conflict Scale (DCS). [Baseline and 4 to 12 weeks post intervention (Decision Aid). Follow up timeframe dependent on participants' completion.]

Secondary Outcome Measures

Name	Time	Method
Anxiety- measured using anxiety component of The Hospital Anxiety and Depression Scale (HADS). <br>[Baseline and 4 to 12 weeks post intervention (Decision Aid). Follow up timeframe depended on participants' rate of completion (DA use and survey response).];Depression- measured using the depression component of The Hospital Anxiety and Depression Scale (HADS)[Baseline and 4 to 12 weeks post intervention (Decision Aid). Follow up timeframe depended on participants' rate of completion (DA use and survey response).];The Arthritis Self-Efficacy Scale (ASES) is a self-administered, disease specific questionnaire developed to measure perceived self-efficacy in people with chronic arthritis. [Baseline and 4 to 12 weeks post intervention (Decision Aid). Follow up timeframe depended on participants' rate of completion (DA use and survey response).]